香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何 責 任。 華 檢 醫 療 控 股 有 限 公 司（「本公司」）宣 佈，下 列 董 事（「董 事」）會（「董事會」）組 成 變 更 已 自 二 零 二 六 年 一 月 十 三 日 起 生 效： 羅 先 生、邰 女 士 及 黃 先 生 均 已 確 認，彼 等 與 董 事 會 並 無 意 見 分 歧，亦 無 任 何 與 其 辭 任 有 關 之 事 宜 需 提 請 聯 交 所 及 本 公 司 股 東 垂 注。 鑒於上述董事辭任，董事委員會的下列變更已自二零二六年一月十三日起生效： 1. 羅 劍 輝 先 生 不 再 擔 任 本 公 司 薪 酬 委 員 會（「薪酬委員會」）成 員； – 1 – 1. 羅 劍 輝 先 生 因 另 有 業 務 發 展 而 辭 任 執 行 董 事。彼 亦 辭 任 本 公 司 其 他 職 務， 包 括 首 席 財 務 官、公 司 秘 書、根 據 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 華檢醫療控股有限公司 呈交日期: 2026年1月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01931 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 3,000,000,000 | USD | | 0.0005 | USD | | 1,500,000 | | 增加 / 減少 (-) | | | | | | | USD | | | | 本月底結存 | | | 3,000,000,000 | USD | | 0.0005 | USD | | 1,500,000 | 本月底法定/註 ...

Group 1 - The core viewpoint of the article is that Xinhua Medical has decided to reduce its stake in Huajian Medical due to various uncertainties, including trading volume, liquidity, and regulatory rules [2] Group 2 - Xinhua Medical's decision to divest was influenced by the trading volume and liquidity of Huajian Medical [2] - The company also considered regulatory rules as a factor in its decision-making process [2]

Group 1 - The core viewpoint of the article is that Xinhua Medical has decided to reduce its holdings in Huajian Medical due to various uncertainties, including trading volume, liquidity, and regulatory rules [2] Group 2 - Xinhua Medical's decision to divest is influenced by the trading volume and liquidity of Huajian Medical [2] - The company is also considering regulatory rules as a factor in its decision-making process [2]

Group 1 - Bitcoin has fallen below $86,000, leading to a collective decline in cryptocurrency-related stocks in the Hong Kong market [1] - The stock of Boyaa Interactive dropped over 5%, while Okcoin Chain, Huaxing Capital Holdings, and New Fire Technology Holdings fell over 4% [1] - Jinyong Investment experienced a decline of over 3% [1] Group 2 - Boyaa Interactive's latest price is $3.370, with a market capitalization of 2.592 billion and a year-to-date decline of 21.14% [2] - Okcoin Chain's latest price is $0.178, with a market capitalization of 0.956 billion and a year-to-date increase of 7.23% [2] - Huaxing Capital Holdings' latest price is $4.370, with a market capitalization of 2.506 billion and a year-to-date increase of 52.80% [2] - New Fire Technology Holdings' latest price is $2.850, with a market capitalization of 2.144 billion and a year-to-date increase of 50.79% [2] - Jinyong Investment's latest price is $3.000, with a market capitalization of 0.770 billion and a year-to-date increase of 5.26% [2] - OSL Group's latest price is $17.490, with a market capitalization of 13.897 billion and a year-to-date increase of 118.63% [2] - Liufeng Financial's latest price is $3.140, with a market capitalization of 12.746 billion and a year-to-date increase of 201.92% [2] - Guofu Quantum's latest price is $2.470, with a market capitalization of 22.477 billion and a year-to-date increase of 212.66% [2] - Xiongan Technology's latest price is $0.077, with a market capitalization of 9.201 million and a year-to-date increase of 4.05% [2] - Guotai Junan International's latest price is $2.540, with a market capitalization of 24.206 billion and a year-to-date increase of 141.90% [2] - Huajian Medical's latest price is $3.980, with a market capitalization of 6.388 billion and a year-to-date increase of 121.11% [2] Group 3 - Bitcoin is currently priced at $85,786, down 3.93%, while Ethereum is priced at $2,939, down 5.5% [2]

Core Viewpoint - Shandong Xinhua Medical Instrument Co., Ltd. plans to sell up to 5% of its stake in Huajian Medical Holdings Co., Ltd. through public market transactions to focus on core business development and improve asset operation efficiency [1][4]. Group 1: Company Overview - Huajian Medical was established in January 2016 with a registered capital of 1.5 million USD and was listed on the Hong Kong Stock Exchange on July 12, 2019, under the stock code 01931.HK [3]. - As of October 2025, Huajian Medical has issued 1,621,488,096 shares, with the wholly-owned subsidiary Huatuo International holding 443,654,371 shares, accounting for 27.36% of the total issued shares, all of which are non-restricted circulating shares [3][4]. Group 2: Financial Data - As of December 31, 2024, Huajian Medical's total assets were 552,388.34 million, and by June 30, 2025, they increased to 615,913.17 million [2][4]. - The total liabilities rose from 176,269.79 million in 2024 to 263,490.81 million in the first half of 2025 [2][4]. - Owner's equity decreased from 376,118.55 million in 2024 to 352,422.36 million by June 30, 2025 [2][4]. - Operating revenue for the year 2024 was 316,241.48 million, while for the first half of 2025, it was 126,959.46 million [2][4]. - Net profit was reported at 26,603.46 million for 2024 and 3,832.44 million for the first half of 2025 [2][4]. Group 3: Shareholding and Future Plans - After the completion of the share reduction, Huatuo International will still hold more than 5% of Huajian Medical's shares and will continue to enjoy shareholder rights and account for its investment using the equity method [2][4]. - The share sale will be executed based on a reasonable assessment of Huajian Medical's stock price, considering market trends and price fluctuations [1][4].

Group 1 - The company Xinhua Medical responded to investor inquiries on December 4, indicating that relevant information regarding Huajian Medical should be monitored through its announcements [2]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 華檢醫療控股有限公司 呈交日期: 2025年12月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01931 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 3,000,000,000 | USD | | 0.0005 | USD | | 1,500,000 | | 增加 / 減少 (-) | | | | | | | USD | | | | 本月底結存 | | | 3,000,000,000 | USD | | 0.0005 | USD | | 1,500,000 | 本月底法定/ ...

Core Viewpoint - Xinhua Medical stated that Huajian Medical is an important associate company, and the company's investment income will be affected by the changes in Huajian Medical's net profit [2] Group 1 - Xinhua Medical uses the equity method to account for its investment in Huajian Medical [2] - Changes in Huajian Medical's net profit will impact Xinhua Medical's investment returns [2]

Core Viewpoint - Huajian Medical (01931.HK) announced a share buyback on November 28, spending HKD 7.724 million to repurchase 1.187 million shares at a price range of HKD 6.37 to HKD 6.53 per share [1] Group 1 - The company executed a buyback of 1.187 million shares [1] - The total expenditure for the buyback was HKD 7.724 million [1] - The buyback price per share ranged from HKD 6.37 to HKD 6.53 [1]